Andrew Huberman's Peptide Protocol
Andrew Huberman brings a rare combination of academic neuroscience expertise and personal experience to peptide discussions. As a Stanford professor, he provides detailed mechanistic explanations of how peptides work at the cellular level, while also sharing his own experience using BPC-157 for spinal issues. His approach emphasizes evidence levels, cycling protocols, and honest acknowledgment of what the research does and does not show.
Background
Stanford Professor of Neurobiology and Ophthalmology and host of the Huberman Lab podcast. Huberman brings a unique scientific perspective to peptide discussions, combining personal experience with detailed mechanistic explanations of how these compounds work at the cellular level.
Peptides Andrew Huberman Has Discussed
BPC-157
Huberman used BPC-157 personally for spinal compression pain and has dedicated podcast episodes to discussing its mechanisms. He emphasizes cycling (8 weeks on, 8+ weeks off) due to angiogenesis concerns.
"I had an L5 compression and I was always in pain... two injections of BPC-157... gone."
JRE Episode #2195
TB-500
Discusses TB-500/Thymosin Beta-4 as a complementary peptide for tissue rejuvenation, often in the context of recovery protocols.
"BPC-157 acts like a repair signal that encourages fibroblasts to migrate to injury sites and start rebuilding."
Huberman Lab: Benefits & Risks of Peptide Therapeutics
NAD+
Huberman has discussed NAD+ IV infusions extensively with Dr. Craig Koniver, positioning it as a foundational intervention for cellular health and recovery.
"If I had to pick one thing for people, engaging in NAD would be it."
Huberman Lab with Dr. Craig Koniver
Epitalon
Discusses Epitalon in the context of telomerase activation and longevity research, while noting the limited clinical data.
"There isn't any clinical data for BPC-157. It's all animals... but so many people will report feeling better."
Huberman Lab podcast
Ipamorelin
Discusses Ipamorelin for growth hormone optimization, always emphasizing conservative dosing and cycling protocols.
"My concern about taking BPC-157 continuously: it promotes vascular growth, and if you have a small tumor, it will vascularize that tumor as well."
Twitter/X (April 2025)
CJC-1295
Discusses CJC-1295 paired with Ipamorelin for synergistic GH release, with detailed explanations of the underlying neuroscience.
"Growth hormone peptides should be taken before bed to align with the natural nocturnal GH pulse."
Huberman Lab podcast
Important Considerations
- !Huberman distinguishes between animal data and human clinical evidence
- !He emphasizes cycling protocols (8 weeks on, 8+ weeks off) due to angiogenesis concerns
- !His scientific background adds credibility but doesn't make his personal use clinical evidence
- !He has noted potential cancer risk with compounds that promote vascular growth
- !Recommends conservative, research-based dosing over aggressive protocols
Frequently Asked Questions
What peptides has Andrew Huberman discussed?
Huberman has discussed BPC-157 (which he used personally for spinal issues), TB-500, NAD+ IV infusions, Epitalon, Ipamorelin, and CJC-1295. He has dedicated full podcast episodes to peptide therapeutics and has interviewed Dr. Craig Koniver about peptide protocols.
Does Andrew Huberman use BPC-157?
Yes, Huberman has confirmed personal use of BPC-157 for an L5 spinal compression that caused chronic pain. He reported that two injections resolved his pain. However, he also warns about the risks of continuous use due to angiogenesis promotion.
What does Huberman say about peptide safety?
Huberman emphasizes cycling (8 weeks on, 8+ weeks off), highlights the lack of human clinical trials for most peptides, and warns about the theoretical cancer risk from angiogenesis-promoting compounds like BPC-157. He advises working with knowledgeable medical professionals.
What is Huberman's approach to growth hormone peptides?
Huberman discusses taking GH peptides before bed on an empty stomach to align with the natural nocturnal growth hormone pulse. He favors conservative dosing and emphasizes the importance of sleep, exercise, and nutrition as foundational interventions.